Related Experiment Video

Updated: May 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

MicroRNA regulation of melanoma progression

Vanessa F Bonazzi1, Mitchell S Stark, Nicholas K Hayward

  • 1Oncogenomics Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia. Vanessa.Bonazzi@qimr.edu.au

Melanoma Research
|January 3, 2012
PubMed

Insights

MicroRNAs (miRNAs) are key epigenetic regulators in melanoma development. Understanding miRNA dysregulation offers potential for new diagnostic markers and targeted melanoma treatments.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Melanoma development involves complex genetic and environmental factors.
  • Epigenetic regulation, particularly by microRNAs (miRNAs), is increasingly recognized in melanomagenesis.
  • miRNAs regulate tumor suppressor genes and oncogenes, playing a crucial role in skin cancer progression.

Purpose of the Study:

  • To review current knowledge on microRNA (miRNA) dysregulation in melanoma.
  • To present a network of miRNA interactions implicated in melanoma progression.
  • To explore the potential utility of miRNAs as diagnostic markers or therapeutic targets in melanoma.

Main Methods:

  • Literature review of studies combining miRNA expression arrays and quantitative reverse transcriptase-PCR (RT-PCR).
  • Analysis of identified deregulated miRNAs during melanoma progression.
  • Investigation into the functional roles and regulatory mechanisms of specific miRNAs.

Main Results:

  • Numerous miRNAs have been found to be deregulated during melanoma progression.
  • Specific miRNAs and their interactions form a network critical to melanoma development.
  • Functional studies are elucidating the roles of these miRNAs in regulating oncogenes and tumor suppressors.

Conclusions:

  • MicroRNA (miRNA) dysregulation is a significant factor in melanoma.
  • Understanding these epigenetic changes can lead to novel diagnostic and therapeutic strategies.
  • Key miRNAs identified may serve as biomarkers or targets for melanoma treatment.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...